Some patients with attention deficit hyperactivity disorder (ADHD) may be concerned that their medication may affect their heart health. So, researchers set out to see if taking ADHD medicine was linked to serious heart problems.
The ADHD medication, Strattera (atomoxetine), received new safety warning labels from the Food and Drug Administration (FDA) in June.
People with attention deficit hyperactivity disorder (ADHD) frequently read warnings on their medication bottles instructing them to avoid usage if they have structural heart problems or another pre-existing heart condition.
While attention deficit-hyperactivity disorder (ADHD) is most commonly associated with children, adults suffer from it too. New research shows certain medications improve adult ADHD symptoms.
The health of a baby in the first five minutes of exiting the womb may be associated with his or her risk of developing attention-deficit hyperactivity disorder (ADHD).
